Long-Term Follow-Up of Patients Undergoing Thalidomide Therapy for Transfusion-Dependent β-Thalassaemia: A Single-Center Experience
International Journal of General Medicine · 2024-04 · Volume 17 · 1729-1738
DOI: 10.2147/ijgm.s462991 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of General Medicine, 2024-04. Verfasst von Weijian Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Zhuhai Clinical Medical College of Jinan University (Zhuhai People's Hospital), Zhuahai, 519050, People's Republic of China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objective
We evaluated the long-term safety and efficacy of thalidomide in the treatment of transfusion-dependent β-thalassemia (TDT).
Methods
Fifty patients with TDT were treated with thalidomide and followed-up for 5 years. Thalidomide at a 50 mg dose was administered once a day after dinner. The dose was increased to 150 mg/d after 3 d if well tolerated. After 1 year of treatment, the hemoglobin (Hb) level was stabilized at its maximum, and thalidomide was gradually reduced and maintained at the minimum dose. The hematological response, transfusion dependence, and haemolytic indicators were assessed.
Results
At 9 month of follow-up, 38 (76%) patients achieved an excellent response, 1 (2%) a good response, 4(8%) a minor response, and 7(14%) did not show a response. The overall response rate was 86%. At 9 months, the Hb level increased from 79.0 ± 13.2 g/L at baseline to 99.0 ± 13.7g/L (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Zhuhai Clinical Medical College of Jinan University (Zhuhai People's Hospital), Zhuahai, 519050, People's Republic of China.
- Department of Haematology, Wuzhou Gongren Hospital, Wuzhou, 543001, People's Republic of China.
- Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 10632, People's Republic of China.
ORCID-Profile: Weijian Zhu, Mufang Huang, Yangqiu Li
Zitieren
APA
Zhu, W., He, Y., Huang, M., Fu, S., Liu, Z., Wang, X., Li, Z., Li, X., Chen, J., & Li, Y. (2024). Long-Term Follow-Up of Patients Undergoing Thalidomide Therapy for Transfusion-Dependent β-Thalassaemia: A Single-Center Experience. International Journal of General Medicine, Volume 17, 1729-1738. https://doi.org/10.2147/ijgm.s462991
Vancouver
Zhu W, He Y, Huang M, Fu S, Liu Z, Wang X, et al. Long-Term Follow-Up of Patients Undergoing Thalidomide Therapy for Transfusion-Dependent β-Thalassaemia: A Single-Center Experience. International Journal of General Medicine. 2024;Volume 17:1729-1738. doi:10.2147/ijgm.s462991
BibTeX
@article{Zhu2024,
author = {Zhu, Weijian and He, Ying and Huang, Mufang and Fu, Shezhu and Liu, Ziyi and Wang, Xiaoqi and Li, Zhixin and Li, Xiaoliang and Chen, Jiangming and Li, Yangqiu},
title = {Long-Term Follow-Up of Patients Undergoing Thalidomide Therapy for Transfusion-Dependent β-Thalassaemia: A Single-Center Experience},
journal = {International Journal of General Medicine},
year = {2024},
volume = {Volume 17},
pages = {1729--1738},
doi = {10.2147/ijgm.s462991}
}
EUVIMED